Correlation Between Jinhe Biotechnology and China State

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and China State at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and China State into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jinhe Biotechnology Co and China State Construction, you can compare the effects of market volatilities on Jinhe Biotechnology and China State and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of China State. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and China State.

Diversification Opportunities for Jinhe Biotechnology and China State

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Jinhe and China is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and China State Construction in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China State Construction and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with China State. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China State Construction has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and China State go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and China State

Assuming the 90 days trading horizon Jinhe Biotechnology Co is expected to generate 1.34 times more return on investment than China State. However, Jinhe Biotechnology is 1.34 times more volatile than China State Construction. It trades about 0.06 of its potential returns per unit of risk. China State Construction is currently generating about -0.03 per unit of risk. If you would invest  456.00  in Jinhe Biotechnology Co on September 12, 2024 and sell it today you would earn a total of  9.00  from holding Jinhe Biotechnology Co or generate 1.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Jinhe Biotechnology Co  vs.  China State Construction

 Performance 
       Timeline  
Jinhe Biotechnology 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.
China State Construction 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in China State Construction are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China State sustained solid returns over the last few months and may actually be approaching a breakup point.

Jinhe Biotechnology and China State Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jinhe Biotechnology and China State

The main advantage of trading using opposite Jinhe Biotechnology and China State positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, China State can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China State will offset losses from the drop in China State's long position.
The idea behind Jinhe Biotechnology Co and China State Construction pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios